Show simple item record

dc.contributor.authorSehestedt, Thomas
dc.contributor.authorOlsen, Michael H.
dc.date.accessioned2019-10-01T11:42:59Z
dc.date.available2019-10-01T11:42:59Z
dc.date.issued2015
dc.identifier.citationSehestedt, T. & Olsen, M.H. 2015. Traditional versus new models of risk prediction. (In Nilsson, P.M., Olsen, M.H. & Laurent, S., eds. Early Vascular Aging (EVA): new directions in cardiovascular protection. Elsevier. p. 213-223). [https://doi.org/10.1016/B978-0-12-801387-8.00021-1]en_US
dc.identifier.isbn978-0-12-801387-8
dc.identifier.urihttp://hdl.handle.net/10394/33388
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/B9780128013878000211
dc.identifier.urihttps://doi.org/10.1016/B978-0-12-801387-8.00021-1
dc.description.abstractRisk stratification for primary prevention of cardiovascular disease is today performed using traditional risk factors such as age, gender, blood pressure, serum cholesterol, smoking habits, and plasma glucose. However, these factors perform poorly in the daily clinic where individual risk prediction is needed. It has been suggested to supplement traditional factors with markers of subclinical organ damage to identify subjects with increased susceptibility for the negative influence from the traditional risk factors. Although many new markers are independently associated with cardiovascular risk, their clinical impact on risk prediction is uncertain. In this chapter the evidence for incremental risk prediction for the most promising markers is reviewed, and it is demonstrated that many new markers provide only modest impact on risk prediction with greatest improvement in intermediate risk groups. However, several aspects are still uncertain and need to be examined in the setting of a randomized study. These include actual net benefit of the use of these new markers in risk stratification after taking into account cost, risk associated with the measurements, and the increased downstream medication and examinations, as well as actual changes in patient and physician behavior and clinical outcomeen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectCardiovascular risken_US
dc.subjectPredictionen_US
dc.subjectRisk chartsen_US
dc.subjectPrimary preventionen_US
dc.subjectSubclinical organ damageen_US
dc.subjectRisk factorsen_US
dc.titleTraditional versus new models of risk predictionen_US
dc.typeBook chapteren_US
dc.contributor.researchID24239100 - Olsen, Michael Hecht


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record